DRF-1042 is an orally active derivative of Camptothecin. DRF-1042 acts to inhibit DNA topoisomerase I. DRF-1042 shows good anticancer activity against a panel of human cancer cell lines including multi-agent resistance (MDR) phenotype[1][2].
Molecular Weight:
408.40
Purity:
98.06
CAS Number:
[200619-13-2]
Formula:
C22H20N2O6
Target:
ADC Payload,Topoisomerase
Application Notes:
MCE Product type: ADC Related
* VAT and and shipping costs not included. Errors and price changes excepted